Abstract
The present work was conducted to examine whether celecoxib, a selective COX-2 inhibitor, 200 mg administered 1 h preoperatively to patients undergoing arthroscopic hip surgery reduces postoperative pain. Fifty-three patients undergoing arthroscopic hip surgery under spinal anesthesia were randomized to receive either 200 mg of celecoxib (Group I) or 200 mg of placebo (Group II) 1 h preoperatively. Narcotic use was monitored for 24 h, and time in recovery room was determined. Visual analog scale (VAS) scores and Short-Form 12 (SF-12), including a physical composite score (PCS) and a mental composite score (MCS), documented pain in recovery, 12 h postoperatively, and 24 h postoperatively. Moreover, time in recovery room was also investigated. We enrolled 27 patients in Group I and 26 patients in Group II. Groups were comparable for patient characteristics. No significant difference was detected in terms of VAS scores and SF-12 in recovery room. Statistically, patients in Group I showed significantly lower pain VAS scores at 12 and 24 h postoperatively. Patients taking celecoxib had significantly higher PCS at 12 and 24 h postoperatively. No difference occurred between groups for the MCS. Patients taking celecoxib also showed a significant reduction in postoperative narcotic consumption. The obtained results from the current study indicate that patients who took celecoxib 200 mg 1 h before arthroscopic hip surgery had a less painful and more rapid recovery. Celecoxib 200 mg as a single preoperative dose could be considered as part of a perioperative analgesic plan in arthroscopic hip surgery.
Similar content being viewed by others
References
Seidenberg AB, An YH (2004) Is there an inhibitory effect of COX-2 inhibitors on bone healing? Pharmacol Res 50:151–156
Bolten WW, Gross M, Brabant T, Weck V, Labenz J (2013) Individual pain treatment with NSAIDs. MMW Fortschr Med 155(3):59–60
Holmes N, Cronholm PF, Webner D (2013) Nonsteroidal anti-inflammatory drug use in collegiate football players. Clin J Sport Med 23(4):283–286
Satoh H, Amagase K, Ebara S, Akiba Y, Takeuchi K (2013) Cyclooxygenase (COX)-1 and COX-2 both play an important role in the protection of the duodenal mucosa in cats. J Pharmacol Exp Ther 344(1):189–195
Bartzatt R (2012) Anti-inflammatory drugs and prediction of new structures by comparative analysis. Antiinflamm Antiallergy Agents Med Chem 11(2):151–160
Li W, Zhai L, Tang Y, Cai J, Liu M, Zhang J (2012) Antitumor properties of taxol in combination with cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian tumor growth in vivo. Oncol Res 20(2–3):49–59
Aalbers J (2012) Benefit versus risk in the use of non-selective NSAIDs and selective COX-2 inhibitors. Cardiovasc J Afr 23(6):356
Vasileiadis GI, Sioutis IC, Mavrogenis AF, Vlasis K, Babis GC, Papagelopoulos PJ (2011) COX-2 inhibitors for the prevention of heterotopic ossification after THA. Orthopedics 34(6):467
Kumar V, Kaur K, Gupta GK, Gupta AK, Kumar S (2013) Developments in synthesis of the antiinflammatory drug, celecoxib: a review. Recent Pat Inflamm Allergy Drug Discov in press
Schachtel BP, McCabe D, Berger M, Zhang R, Sanner KM, Savino L, Rizouk J, Schachtel EP (2011) Efficacy of low-dose celecoxib in patients with acute pain. J Pain 12(7):756–763
Kazerooni R, Bounthavong M, Tran JN, Boggie DT, Meyer RS (2012) Retrospective evaluation of inpatient celecoxib use after total hip and knee arthroplasty at a Veterans Affairs Medical Center. J Arthroplasty 27(6):1033–1040
Ekman EF, Wahba M, Ancona F (2006) Analgesic efficacy of perioperative celecoxib in ambulatory arthroscopic knee surgery: a double-blind, placebo-controlled study. Arthroscopy 22(6):635–642
Ittichaikulthol W, Prachanpanich N, Kositchaiwat C, Intapan T (2010) The post-operative analgesic efficacy of celecoxib compared with placebo and parecoxib after total hip or knee arthroplasty. J Med Assoc Thai 93(8):937–942
Tannenbaum H, Berenbaum F, Reginster JY, Zacher J, Robinson J (2004) Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib. Ann Rheum Dis 63:1419–1426
Reuben SS, Sklar J (2000) Pain management in patients who undergo outpatient arthroscopic surgery of the knee. J Bone Joint Surg Am 82(12):1754–1766
Bardou M, Barkun AN (2010) Preventing the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: From risk factor identification to risk factor intervention. Joint Bone Spine 77(1):6–12
Bardou M, Barkun AN, Ghosn J, Hudson M, Rahme E (2004) Effect of chronic intake of NSAIDs and cyclooxygenase 2-selective inhibitors on esophageal cancer incidence. Clin Gastroenterol Hepatol 2(10):880–887
Modica M, Vanhems P, Tebib J (2005) Comparison of conventional NSAIDs and cyclooxygenase-2 inhibitors in outpatients. Joint Bone Spine 72(5):397–402
Daniels S, Robbins J, Christine R (2009) Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies. Clin Ther 31(6):1192–1208
Noguchi M, Kimoto A, Kobayashi S, Yoshino T, Miyata K, Sasamata M (2005) Effect of celecoxib, a cyclooxygenase-2 inhibitor, on the pathophysiology of adjuvant arthritis in rat. Eur J Pharmacol 513(3):229–235
Wong SYS, Wong KYK, Wie L, Ogston SA, MacDonald TM (2003) Randomised, crossover study comparing celecoxib with nonselective NSAIDs on ambulatory blood pressure of treated hypertensive patients. Am J Hypertens 16(5):65
Whalton A (2000) The celecoxib long-term safety study (CLASS): celecoxib is associated with less renal toxicity compared to conventional NSAIDs. Am J Gastroenterol 95(9):2644
Malmstrom K, Fricke JR, Kotey P, Kress B, Morrison B (2002) A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model. Clin Ther 24(10):1549–1560
Huang YM, Wang CM, Wang CT, Lin WP, Horng LC, Jiang CC (2008) Perioperative celecoxib administration for pain management after total knee arthroplasty-a randomized, controlled study. BMC Musculoskeletal Disorders 9:77–82
Chavez ML, DeKorte CJ (2003) Valdecoxib: a review. Clin Ther 25(3):817–851
Lee LH, Irwin MG, Yao TJ, Yuen MK, Cheung CW (2008) Timing of intraoperative parecoxib analgesia in colorectal surgery. Acute Pain 10(3):23–130
Kiely JM, Brasel KJ, Guse CE, John A (2006) Weigelt correlation of SF-12 and SF-36 in a trauma population. J Surg Res 132(2):214–218
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, Z., Zhu, W., Zhu, L. et al. Efficacy of celecoxib for pain management after arthroscopic surgery of hip: a prospective randomized placebo-controlled study. Eur J Orthop Surg Traumatol 24, 919–923 (2014). https://doi.org/10.1007/s00590-013-1359-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-013-1359-y